Home・Elenco Azioni・Insulet Corp

Insulet Corp

Aperta

SettoreSettore sanitario

167.09 1.33

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

164.31

Massimo

172.83

Metriche Chiave
By Trading Economics
Entrata	-11M 91M
Vendite	-22M 762M
P/E Media del settore	38.3 62.58
EPS	1.42
Margine di Profitto	11.96
Dipendenti	5,400
EBITDA	-23M 154M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+34.17% upside

Dividendi
By Acuity
Utili prossimi	5 ago 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-278M 12B
Apertura precedente	165.76
Chiusura precedente	167.09

Notizie sul Sentiment di mercato

By Acuity

63%

37%

295 / 340 Classifica in Healthcare

Insulet Corp Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

27 lug 2026, 20:06 UTC

Insulet Corp shares are higher today, reflecting broader market trends despite an earlier pullback from a session high. No specific news was identified.

24 lug 2026, 22:26 UTC

Insulet Corp shares are lower in after-market hours, following a decline from earlier session lows. No specific company news was identified to explain the movement.

22 lug 2026, 20:01 UTC

News

Insulet Corp shares are lower amid a class action lawsuit alleging securities fraud related to safety claims about its Omnipod products.

20 lug 2026, 18:36 UTC

News

Insulet Corp is gaining today after being identified as a healthcare stock likely to deliver sustainable market-beating returns, despite ongoing legal challenges.

Confronto tra pari

Modifica del prezzo

Insulet Corp Previsione

Obiettivo di Prezzo

By TipRanks

34.17% in crescita

Previsioni per 12 mesi

Media 221.38 USD 34.17%

Alto 294 USD

Basso 172 USD

Basato su 22 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Insulet Corp - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

22 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 22 che hanno fornito valutazioni azionarie a Insulet Corp - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

295 / 340 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Insulet Corp

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.